1. COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma. (2nd August 2021) Authors: Ramasamy, Karthik; Sadler, Ross; Jeans, Sally; Varghese, Sherin; Turner, Alison; Larham, Jemma; Gray, Nathanael; Barrett, Joe; Bowcock, Stella; Cook, Gordon; Kyriakou, Chara; Smith, Dean; Drayson, Mark; Basu, Supratik; Moore, Sally; McDonald, Sarah; Gooding, Sarah; Javaid, Muhammad K. Journal: British journal of haematology Issue: Volume 196:Number 1(2022) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COVID‐19 in haematology patients: a multicentre West Midlands clinical outcomes analysis on behalf of the West Midlands Research Consortium. (5th November 2020) Authors: Morrissey, Hana; Ball, Patrick; Mandal, Anandadeep; Nevil, Alan; Paneesha, Shankara; Basu, Supratik; Karim, Farheen; Hossain, Md Imran; Phillips, Neil; Khawaja, Jahanzeb; Stone, Jackie; Murray, Duncan; Randall, Katie; Murthy, Vidhya; Kishore, Bhuvan; Nikolousis, Manos; Pratt, Guy; Neilson, Jeff; ... Journal: British journal of haematology Issue: Volume 192:Number 1(2021) Page Start: e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial. Issue 11 (November 2021) Authors: Facon, Thierry; Kumar, Shaji K; Plesner, Torben; Orlowski, Robert Z; Moreau, Philippe; Bahlis, Nizar; Basu, Supratik; Nahi, Hareth; Hulin, Cyrille; Quach, Hang; Goldschmidt, Hartmut; O'Dwyer, Michael; Perrot, Aurore; Venner, Christopher P; Weisel, Katja; Mace, Joseph R; Raje, Noopur; Tiab, Mourad... Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. DPACE‐based chemotherapy in the era of myeloma novel agents: A UK multicentre study. (21st April 2020) Authors: Djebbari, Faouzi; De Abrew, Kanchana; Salhan, Beena; Panitsas, Fotios; Hossain, Md Imran; Eyre, Toby A; Willan, John; Ramasamy, Karthik; Basu, Supratik; Jenner, Matthew; Kothari, Jaimal Journal: European journal of haematology Issue: Volume 105:Number 2(2020) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset. Issue 6 (26th June 2022) Authors: Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Al-Kaisi, Firas; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Ander... Journal: HemaSphere Issue: Volume 6:Issue 6(2022) Page Start: e738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Elevated, combined serum free light chain levels and increased mortality: a 5-year follow-up, UK study. Issue 11 (25th August 2012) Authors: Anandram, Seetharam; Assi, Lakhvir Kaur; Lovatt, Tracy; Parkes, Jayne; Taylor, Joanne; Macwhannell, Alan; Jacob, Abraham; Handa, Sunil; Harding, Stephen; Basu, Supratik Journal: Journal of clinical pathology Issue: Volume 65:Issue 11(2012) Page Start: 1036 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK‐wide real‐world cohort of relapsed myeloma patients. (31st January 2023) Authors: Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Al‐Kaisi, Firas; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Ander... Journal: British journal of haematology Issue: Volume 201:Number 1(2023) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Haematological manifestations of COVID‐19: From cytopenia to coagulopathy. (31st August 2020) Authors: Agbuduwe, Charles; Basu, Supratik Journal: European journal of haematology Issue: Volume 105:Number 5(2020) Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma. Issue 8 (2nd July 2020) Authors: Weisel, Katja; Dimopoulos, Meletios; Moreau, Philippe; Yagci, Munci; Larocca, Alessandra; Kanate, Abraham S.; Vural, Filiz; Cascavilla, Nicola; Basu, Supratik; Johnson, Peter; Byeff, Peter; Hus, Marek; Rodríguez-Otero, Paula; Muelduer, Ercan; Anttila, Pekka; Hayden, Patrick J.; Krauth, Maria-Ther... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 1850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immune response to COVID‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response. (17th February 2022) Authors: Ramasamy, Karthik; Sadler, Ross; Jeans, Sally; Weeden, Paul; Varghese, Sherin; Turner, Alison; Larham, Jemma; Gray, Nathanael; Carty, Oluremi; Barrett, Joe; Bowcock, Stella; Oppermann, Udo; Cook, Gordon; Kyriakou, Chara; Drayson, Mark; Basu, Supratik; Moore, Sally; McDonald, Sarah; Gooding, Sarah... Journal: British journal of haematology Issue: Volume 197:Number 3(2022) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗